1. Home
  2. DV vs AUPH Comparison

DV vs AUPH Comparison

Compare DV & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$11.50

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.25

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DV
AUPH
Founded
2008
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
DV
AUPH
Price
$11.50
$16.25
Analyst Decision
Buy
Buy
Analyst Count
17
4
Target Price
$16.56
$17.25
AVG Volume (30 Days)
2.0M
1.2M
Earning Date
11-07-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
0.55
Revenue
$733,324,000.00
$265,808,000.00
Revenue This Year
$17.93
$21.76
Revenue Next Year
$10.61
$16.45
P/E Ratio
$43.73
$29.54
Revenue Growth
14.86
20.62
52 Week Low
$7.64
$6.55
52 Week High
$23.11
$16.54

Technical Indicators

Market Signals
Indicator
DV
AUPH
Relative Strength Index (RSI) 61.29 63.13
Support Level $11.15 $16.00
Resistance Level $11.48 $16.54
Average True Range (ATR) 0.28 0.41
MACD 0.06 -0.03
Stochastic Oscillator 83.98 80.58

Price Performance

Historical Comparison
DV
AUPH

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: